The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
18
No.
41
October 23, 1992
- Fred Hutchinson Center Wins $140 Mil. Contract To Coordinate NIH Women’s Health Initiative
- In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day
- Calif., Illinois Enact ACCC Model Law On Reimbursement
- Wyden, Schroeder Bill Would Require NIH To Test RU 486
- DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts
- ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing
TCL
Vol.
18
No.
42
October 30, 1992
- House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms
- In Brief: Jordan, Fisher Win Brinker Awards; AFUD Forms 100th Us Too Prostate Cancer Support Group
- Mason Asks For Better Technology Transfer In Cancer Prevention
- South Carolina Politicos Join Hollings Oncology Center Section
- DCT Board Ok’s PA, BRM Contract Concepts
- DCPC Board Ok’s Grant Programs In Prevention, Public Education
TCL
Vol.
18
No.
43
November 06, 1992
- NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority
- In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced
- Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice
- Breast Cancer Activist, Radiologist Are Added To Special Commission
- Bypass Budget Seeks Double Funding for Breast Cancer Research
TCL
Vol.
18
No.
44
November 13, 1992
- NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation
- In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program
- FDA Proposes Office For Patients With Life Threatening Disease
- DCT Board Sends Letter Opposing Bill Requiring Research On RU 486
- DCPC Bard Approves Concepts For New Grant Programs
TCL
Vol.
18
No.
45
November 20, 1992
- Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer
- In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office
- Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws
- Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry
- DCE To Provide $3.4 Mil. For Follow-Up Of DES Daughters; Board k’s Tw RFAs, Contracts
TCL
Vol.
18
No.
46
November 27, 1992
- U.S. Radiologists Criticize Canadian Study Of Mammography Screening Showing No Benefit
- In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget
- Canadian Responds To Criticism Of Study, Says Results Not ‘Politically Correct’
- ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment
- Foundation Issues Call For Tobacco Policy Research Proposals
TCL
Vol.
18
No.
47
December 04, 1992
- DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says
- In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two
- NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program
- Final stats On FY92 Budget; Success Rate Was 35 Percent
- DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs
- NCI to Recompete contracts for Frederick
- NIH Funding Strategies, UICC Fellowships
TCL
Vol.
18
No.
48
December 11, 1992
- Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center
- In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship
- Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’
- NCI relaxes Core Grants Support For Clinical Trials Research
- Final Issue Of 1992
- NINDS Awards Grants For Brain Tumor Centers